Immune reconstitution following allogeneic peripheral blood stem cell transplants

被引:0
|
作者
S Shenoy
T Mohanakumar
G Todd
W Westhoff
K Dunnigan
DR Adkins
RA Brown
JF DiPersio
机构
[1] St Louis Children’s Hospital,Department of Pediatric Hematology
[2] Washington University School of Medicine,Oncology (Division)
[3] St Louis Children’s Hospital,Department of Surgery and Pathology
[4] Washington University School of Medicine,Department of Bone Marrow Transplantation and Stem Cell Biology (Division)
[5] St Louis Children’s Hospital,Department of Biostatistics
[6] Washington University School of Medicine,undefined
[7] St Louis Children’s Hospital,undefined
[8] Washington University School of Medicine,undefined
来源
Bone Marrow Transplantation | 1999年 / 23卷
关键词
immune reconstitution; PBSCT; cytokines; lymphocyte function; GVHD;
D O I
暂无
中图分类号
学科分类号
摘要
Growth factor-mobilized peripheral blood stem cells (PBSCs) engraft rapidly in myeloablated recipients compared to conventional BM, but this procedure also mobilizes mature lymphocytes and monocytes which can impact immune reconstitution and GVHD. Hence, we serially evaluated immune reconstitution and cytokine expression in PBSCT recipients in the first year. Engraftment of neutrophils and monocytes stabilized early but NK cells, B cells and CD4+ T cell numbers were significantly (P < 0.05) low with persistently reversed cd4:cd8 ratios. nk function remained low throughout the first year. the quantitative decrease in cd4+ T cells resulted in significantly decreased proliferation in response to mitogens and alloHLA antigens. Yet, a qualitative analysis of T cell function measured by Ca++ influx after T cell activation with antiCD3 as well as T-dependent polyclonal Ig secretion by mitogen-stimulated B cells was preserved even early post transplant. TNFα mRNA was detected in almost all recipients in the first year. IL-10 mRNA was detected in 77%, IL-2 in 22% and IFNγ in 44% of recipients in the first 6 months. Only 30% expressed IL-10 in the second 6 months post transplant while expression of IL-2 and IFNγ was detected in 38% and 46% respectively. Thirty-seven percent of PBSCT recipients developed grades II–IV acute GVHD but 72% went on to develop chronic extensive GVHD at a median of 120 days. Sixty-two percent developed CMV viremia and 5.4% developed overt CMV disease in the first year post PBSCT. Lymphocyte engraftment is quantitatively delayed but CD4 functions are preserved while NK numbers and function are compromised post PBSCT. IL-10 expression decreases after the first 6 months post transplant while TNFα is continually expressed. The balance between quantitative lymphocyte reconstitution and qualitative lymphocyte functions as well as changes in lymphokine patterns may influence infection and GVHD and thus the clinical outcome post PBSCT.
引用
收藏
页码:335 / 346
页数:11
相关论文
共 50 条
  • [21] ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN THE TREATMENT OF LEUKEMIA
    曹履先
    胡亮钉
    陈虎
    邓春江
    裴雪涛
    江岷
    王波
    阎安文
    秦茂全
    ChineseJournalofCancerResearch, 1997, (02) : 142 - 145
  • [22] Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection
    Gallez-Hawkins, G
    Thao, L
    Lacey, SF
    Martinez, J
    Li, XL
    Franck, AE
    Lomeli, NA
    Longmate, J
    Diamond, DJ
    Spielberger, R
    Forman, SJ
    Zaia, JA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (11) : 890 - 902
  • [23] Immune Reconstitution Following Allogeneic HSCT in Hematological Diseases
    Naseeb, Summaira
    Ahmed, Parvez
    Nasir, Shahzad
    Zahur, Umar
    Mahmood, Syed Karman
    Chaudhry, Brig Qamar Un N.
    Rahman, Khalil Ur
    Peter, Hina
    Fatima, Mehroz
    BLOOD, 2024, 144 : 7337 - 7337
  • [24] Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation:: Comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts
    Martínez, C
    Urbano-Ispizua, A
    Rozman, C
    Marín, P
    Rovira, M
    Sierra, J
    Montfort, N
    Carreras, E
    Montserrat, E
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (03) : 561 - 568
  • [25] Immune reconstitution and stem cell sources
    Smith, FO
    Thomson, BG
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (2-3): : 187 - 203
  • [26] Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans
    Peggs, K. S.
    CYTOTHERAPY, 2006, 8 (05) : 427 - 436
  • [27] Peripheral Blood Eosinophilia Has a Favorable Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation
    Kim, Dong Hwan
    Popradi, Gizelle
    Xu, Wei
    Gupta, Vikas
    Kuruvilla, John
    Wright, Janice
    Messner, Hans A.
    Lipton, Jeffrey H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (04) : 471 - 482
  • [28] T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation
    Lucarelli B.
    Merli P.
    Strocchio L.
    Cefalo M.G.
    Brescia L.P.
    Locatelli F.
    Current Stem Cell Reports, 2015, 1 (4) : 206 - 214
  • [29] Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children
    Schwinger, Wolfgang
    Weber-Mzell, Daniela
    Zois, Birgit
    Rojacher, Tanja
    Benesch, Martin
    Lackner, Herwig
    Dornbusch, Hans Juergen
    Sovinz, Petra
    Moser, Andrea
    Lanzer, Gerhard
    Schauenstein, Konrad
    Ofner, Petra
    Handgretinger, Rupert
    Urban, Christian
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (01) : 76 - 84
  • [30] Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens
    Jimenez, M.
    Ercilla, G.
    Martinez, C.
    LEUKEMIA, 2007, 21 (08) : 1628 - 1637